Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrishan S Samuel

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 22, 2005
Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive ratsEdna D Lekgabe, Helen Kiriazis, Chongxin Zhao, et al.
Drug Discovery Today|August 5, 2008
Relaxin family peptide receptors--from orphans to therapeutic targetsEmma T van der Westhuizen, Michelle L Halls, Chrishan S Samuel, et al.
ACS Pharmacology & Translational Science|May 18, 2023
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1Mohammed Akhter Hossain, Praveen Praveen, Nurhayati Ahmad Noorzi, et al.
Plos One|December 2, 2021
The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosisHabtamu B Derseh, Jason Q D Goodger, Jean-Pierre Y Scheerlinck, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2014
Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathyBrooke M Huuskes, Andrea F Wise, Alison J Cox, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2008
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2Ishanee Mookerjee, Tim D Hewitson, Michelle L Halls, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2023
The protective effects of a novel AT<sub>2</sub> receptor agonist, β-Pro<sup>7</sup>Ang III in ischemia-reperfusion kidney injuryTingfang Zhang, Yifang Li, Andrea F Wise, et al.
Experimental Lung Research|November 26, 2019
The efficacy of pirfenidone in a sheep model of pulmonary fibrosisSasika N V Dewage, Louise Organ, Emmanuel Koumoundouros, et al.
European Heart Journal|November 14, 2006
Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillationPeter M Kistler, Prashanthan Sanders, Miodrag Dodic, et al.
The Journal of Biological Chemistry|October 2, 2012
Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxinLinda J Chan, K Johan Rosengren, Sharon L Layfield, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|June 22, 2005
Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive ratsEdna D Lekgabe, Helen Kiriazis, Chongxin Zhao, et al.
Drug Discovery Today|August 5, 2008
Relaxin family peptide receptors--from orphans to therapeutic targetsEmma T van der Westhuizen, Michelle L Halls, Chrishan S Samuel, et al.
ACS Pharmacology & Translational Science|May 18, 2023
Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1Mohammed Akhter Hossain, Praveen Praveen, Nurhayati Ahmad Noorzi, et al.
Plos One|December 2, 2021
The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosisHabtamu B Derseh, Jason Q D Goodger, Jean-Pierre Y Scheerlinck, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 15, 2014
Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathyBrooke M Huuskes, Andrea F Wise, Alison J Cox, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2008
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2Ishanee Mookerjee, Tim D Hewitson, Michelle L Halls, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2023
The protective effects of a novel AT<sub>2</sub> receptor agonist, β-Pro<sup>7</sup>Ang III in ischemia-reperfusion kidney injuryTingfang Zhang, Yifang Li, Andrea F Wise, et al.
Experimental Lung Research|November 26, 2019
The efficacy of pirfenidone in a sheep model of pulmonary fibrosisSasika N V Dewage, Louise Organ, Emmanuel Koumoundouros, et al.
European Heart Journal|November 14, 2006
Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillationPeter M Kistler, Prashanthan Sanders, Miodrag Dodic, et al.
The Journal of Biological Chemistry|October 2, 2012
Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxinLinda J Chan, K Johan Rosengren, Sharon L Layfield, et al.
Pageof 18